Hims & Hers vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

Willow beats Hims & Hers overall, scoring 9.4/10 vs 7.8/10. Willow is more affordable at $160/mo vs $199/mo. Choose Hims & Hers for users who want glp-1 access from a well-known, publicly trad. Choose Willow for users who want a balance of quality care and reasonable pric.

A side-by-side comparison of Hims & Hers and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Hims & Hers

#25 of 39
7.8/10

One of the largest and most recognized telehealth platforms in the US, offering compounded GLP-1 medications with a polished user experience and strong brand trust.

Visit Hims & Hers
Higher Rated

Willow

#1 of 39
9.4/10

Personalized GLP-1 weight loss with ongoing clinical support. The highest verified conversion rate among comprehensive care platforms.

Visit Willow
FeatureHims & HersWillow
Our Score7.8/109.4/10
Starting Price$199/mo$160/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoNo
Best ForUsers who want GLP-1 access from a well-known, publicly traded telehealth brandUsers who want a balance of quality care and reasonable pricing
Ranking#25#1

Pros & Cons Compared

Hims & Hers

Pros

  • +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
  • +Polished app and web experience — one of the best user interfaces in telehealth
  • +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
  • +Massive brand recognition means extensive customer support infrastructure and resources

Cons

  • Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
  • Compounded only — no brand-name Wegovy or Zepbound through their platform
  • Generic support experience — large patient volume means you're less likely to get personalized attention
  • Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product

Willow

Pros

  • +Includes monthly provider check-ins and dose adjustments at no extra cost
  • +Switch between brand-name and compounded mid-treatment without restarting
  • +$160/mo all-in — no consultation fees, no shipping charges, no lab surcharges
  • +90%+ patient retention rate after 3 months per their published outcomes data

Cons

  • Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
  • Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Hims & Hers with a score of 9.4/10 vs 7.8/10. If budget is your priority, Willow starts at $160/mo compared to Hims & Hers's $199/mo. Willow offers both brand-name and compounded medications, giving you more flexibility. Choose Hims & Hers if you want: users who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Willow if you want: users who want a balance of quality care and reasonable pricing.

Try Hims & Hers

Starting at $199/mo

Visit Hims & Hers

Try Willow

Starting at $160/mo

Visit Willow